Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice

Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates expression of low-density lipoprotein (LDL) receptors via receptor internalization and subsequent lysosomal degradation. Thus, an anti-PCSK9 antibody is well known as an anti-hyperlipidemia drug. Here, we aimed to develop vaccine for a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Kawakami, Ryo, Nozato, Yoichi, Nakagami, Hironori, Ikeda, Yuka, Shimamura, Munehisa, Yoshida, Shota, Sun, Jiao, Kawano, Tomohiro, Takami, Yoichi, Noma, Takahisa, Rakugi, Hiromi, Minamino, Tetsuo, Morishita, Ryuichi
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5811007/
https://ncbi.nlm.nih.gov/pubmed/29438441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0191895
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados